Device Trial Radar · NCT02370342
Robot-Assisted Ultrasound for Thermal Ablative Therapy in Treating Patients With Small Kidney Masses Undergoing Surgery
Last checked: Nov 19, 2026Latest source record: Dec 20, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Dec 18, 2017
Primary completion
Dec 18, 2018
Study completion Dec 18, 2019
Sponsor
- Lead sponsor
- University of Southern CaliforniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Feb 24, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial studies a type of ultrasound called robot-assisted laparoscopic high-intensity focused ultrasound for performing thermal ablative therapy, or sound wave therapy, in treating patients with small kidney masses undergoing partial removal of the kidney. The robot-assisted ultrasound probe takes images of the kidney to help doctors locate the mass. The probe then uses high frequency sound waves to target and ablate (or destroy) the kidney mass, which may be a cancerous tumor or benign tissue. Surgery is then performed to remove the part of the kidney with the mass. Robot-assisted laparoscopic high-intensity focused ultrasound for thermal ablative therapy may be safer and help doctors see the tumor better when performing kidney surgery.
Conditions
- Renal Carcinoma
- Renal Mass
Interventions
Robot-Assisted Laparoscopic SurgeryProcedure
Undergo robot-assisted laparoscopic HIFU ablation
High-Intensity Focused Ultrasound AblationProcedure
Undergo robot-assisted laparoscopic HIFU ablation
Therapeutic Laparoscopic SurgeryProcedure
Undergo laparoscopic partial nephrectomy
Sonatherm 600i Ultrasonic Lesion Generating SystemDevice
Device used for high-intensity focused ultrasound ablation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Planned ablation volumeTime frame: Baseline (day of surgery)
- Necrosis volumeTime frame: Baseline (day of surgery)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Keck Hospital of USC
Los Angeles, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.